RTX
RTX
$186.39
+2.51%
RTX Corporation is a leading global aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, operating across three core segments: Collins Aerospace (diversified aerospace supplier), Pratt & Whitney (commercial and military aircraft engines), and Raytheon (defense prime contractor for missiles, sensors, and communications). The company is a dominant market player, uniquely positioned with roughly equal exposure to both commercial aerospace and government defense markets, making it a critical supplier to major OEMs and the U.S. military. The current investor narrative is heavily driven by geopolitical tensions, as recent news of U.S.-Iran conflict escalation has triggered rallies in defense stocks, while ongoing debates center on the execution risks and massive revenue opportunities tied to multi-billion dollar missile defense programs like the 'Golden Dome' system.…
RTX
RTX
$186.39
Related headlines
RTX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on RTX's 12-month outlook, with a consensus price target around $242.31 and implied upside of +30.0% versus the current price.
Average Target
$242.31
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$149 - $242
Analyst target range
Insufficient analyst coverage data is available to provide a detailed consensus view; the provided data includes only 8 analysts for estimates but lacks a consensus recommendation, average price target, or target range. This limited coverage for a company of RTX's size ($246 billion market cap) is unusual and may indicate that the provided dataset is incomplete. Typically, a stock of this magnitude would have extensive coverage from dozens of analysts; the absence of this data here prevents a standard analysis of implied upside/downside and sentiment distribution. The available institutional ratings from recent months show a mix of 'Buy', 'Overweight', and 'Neutral' actions, with UBS downgrading from Buy to Neutral in early January 2026, which may have contributed to the stock's subsequent weakness. Without a full set of targets, it is difficult to gauge the strength of analyst conviction, but the recent news flow centered on geopolitical risk and major defense programs suggests analyst views are likely bifurcated between those focusing on near-term execution risks and those emphasizing long-term backlog and demand visibility.
Bulls vs Bears: RTX Investment Factors
The investment debate for RTX centers on a tension between its strong fundamental growth drivers and its fully valued, expectation-laden stock price. The bull case is supported by robust 12% revenue growth, a fortress balance sheet with $7.9B in FCF, and a unique dual-market exposure that benefits from both aerospace recovery and defense spending. However, the bear case presents compelling evidence that the stock has already priced in this optimism, trading at a trailing P/E of 36.5x near its historical peak while showing signs of margin pressure and weak technical momentum. Currently, the bearish arguments on valuation and momentum appear to have stronger evidence, as the stock's 3-month decline of -6.34% suggests the market is questioning its ability to meet high expectations. The single most important tension is whether the company can translate its massive defense backlog (e.g., Golden Dome) into sustained, high-margin earnings growth fast enough to justify its premium multiple, or if execution risks and cost overruns will lead to disappointing profitability and multiple compression.
Bullish
- Robust Revenue Growth & Dual Market Exposure: Q4 2025 revenue grew 12.09% YoY to $24.24B, accelerating from Q1's $20.31B. This growth is driven by the company's unique, balanced exposure to both commercial aerospace recovery and heightened defense spending due to geopolitical tensions, providing a diversified and resilient revenue stream.
- Strong Free Cash Flow & Healthy Balance Sheet: The company generated $7.94B in TTM free cash flow with a manageable debt-to-equity ratio of 0.61. This robust cash generation supports the dividend (53.09% payout ratio), funds growth, and provides a defensive cushion, especially important given the stock's low beta of 0.306.
- Defensive Low-Beta Profile Amid Volatility: With a beta of 0.306, RTX is significantly less volatile than the market. This characteristic has allowed it to outperform the S&P 500 by 5.63% over the past month despite a broader 3-month decline, making it a relative safe haven during market stress, as evidenced by recent defense stock rallies on Iran news.
- Significant Forward Earnings Growth Priced In: The forward P/E of 24.49x is substantially lower than the trailing P/E of 36.54x, implying the market expects a strong earnings recovery. Analyst estimates point to an average EPS of $9.86 for the coming period, supporting this growth narrative and potentially justifying the current premium valuation.
Bearish
- Elevated Valuation with High Expectations: The trailing P/E of 36.54x is near the top of its recent historical range (low of ~19x), and the forward P/E of 24.49x trades at a premium to the industrials sector. This leaves little room for error; any earnings disappointment could trigger significant multiple compression.
- Recent Profitability and Margin Pressure: Q4 2025 net margin declined sequentially to 6.69% from 8.53% in Q3, and gross margin of 19.46% was below the TTM average of 20.08%. This indicates potential cost inflation or operational inefficiencies that could threaten earnings growth needed to justify the high P/E.
- Pronounced Technical Downtrend & Weak Momentum: The stock is down 6.34% over the past 3 months and 13% from its 52-week high of $214.5, signaling a breakdown from its uptrend. The recent 1-month bounce of 6.37% appears to be a mean reversion within a broader corrective phase, lacking conviction for a sustained recovery.
- Execution Risk on Major Defense Contracts: News highlights skyrocketing cost projections (e.g., Golden Dome's potential $1.2T price tag) and supply chain vulnerabilities (reliance on Chinese rare earths). These factors introduce significant uncertainty around the profitability and timing of the very programs underpinning the bull case.
RTX Technical Analysis
The stock is in a pronounced downtrend from its recent highs, with a 1-year price change of +27.24% but a significant 3-month decline of -6.34%, indicating a sharp reversal of momentum. The current price of $185.60 sits approximately 29% above its 52-week low of $140.47 but 13% below its 52-week high of $214.5, positioning it in the lower-middle of its annual range, suggesting the stock has given back a substantial portion of its gains and may be seeking a new support level. Recent momentum shows a stark divergence: the stock has gained 6.37% over the past month, which contrasts sharply with the negative 3-month and 6-month performance, potentially signaling a short-term oversold bounce or mean reversion attempt within a broader corrective phase. The stock's beta of 0.306 indicates it is significantly less volatile than the broader market, a characteristic of a large-cap defense name, which has likely muted its downside during the recent pullback relative to the S&P 500's 15.14% gain over the same 3-month period. Key technical levels are clearly defined, with immediate resistance near the 52-week high of $214.5 and support at the 52-week low of $140.47; a decisive break above the $200-$205 zone would be needed to signal a resumption of the uptrend, while a failure to hold above $180 could open a path toward the $170 support area. The stock's low beta of 0.306 suggests it is a relatively defensive holding, which is consistent with its recent outperformance against the S&P 500 on a 1-month basis (relative strength of +5.63) despite its absolute price decline.
Beta
0.31
0.31x market volatility
Max Drawdown
-19.3%
Largest decline past year
52-Week Range
$140-$215
Price range past year
Annual Return
+27.8%
Cumulative gain past year
| Period | RTX Return | S&P 500 |
|---|---|---|
| 1m | +5.3% | -1.6% |
| 3m | -4.4% | +11.7% |
| 6m | +0.0% | +6.3% |
| 1y | +27.8% | +22.2% |
| ytd | -0.5% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
RTX Fundamental Analysis
Revenue growth remains robust, with Q4 2025 revenue of $24.24 billion representing a 12.09% year-over-year increase, continuing a multi-quarter trend of accelerating growth from Q1 2025's $20.31 billion. The growth is broad-based across segments, with Pratt & Whitney leading at $17.13 billion in the latest period, followed by Collins Aerospace at $15.36 billion and Raytheon Intelligence & Space at $14.66 billion. Profitability is solid, with the company reporting net income of $1.62 billion in Q4 2025 and a net margin of 6.69%, though this represents a sequential decline from Q3's net margin of 8.53%. Gross margin for Q4 2025 was 19.46%, which is slightly below the trailing-twelve-month gross margin of 20.08%, indicating some recent pressure, while operating margin stood at 9.45% for the quarter. The balance sheet and cash flow position are healthy, with a debt-to-equity ratio of 0.61 and a current ratio of 1.03, indicating manageable leverage and adequate short-term liquidity. The company generated substantial free cash flow, with TTM free cash flow of $7.94 billion, providing ample internal funding for growth initiatives and its dividend, which has a payout ratio of 53.09%. Return on equity (ROE) of 10.32% and return on assets (ROA) of 4.05% reflect efficient, albeit not spectacular, capital allocation within the capital-intensive aerospace and defense industry.
Quarterly Revenue
$24.2B
2025-12
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.19%
Latest Quarter
Free Cash Flow
$7.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is RTX Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is elevated at 36.54x, while the forward PE is significantly lower at 24.49x, indicating the market is pricing in a substantial recovery in earnings growth over the next twelve months. Compared to the Industrials sector, RTX's forward PE of 24.49x trades at a premium; while a precise industry average is not provided in the data, a forward PE in the mid-20s is generally above the market average, suggesting investors are willing to pay for its dual aerospace/defense exposure and perceived stability. Historically, the stock's own trailing PE has fluctuated widely, from a low near 19x in early 2024 to a high of 38x at the end of 2025; the current 36.54x is near the top of this recent historical range, indicating the stock is pricing in optimistic expectations, leaving little room for earnings disappointment. The Price-to-Sales (PS) ratio of 2.78x and EV-to-Sales of 3.16x provide additional context, confirming the stock is not cheap on a sales basis either, which is typical for a mature industrial with moderate net margins. The PEG ratio of 0.91, based on trailing earnings, suggests the stock may be reasonably valued relative to its growth rate, but this metric is highly sensitive to the growth estimate used.
PE
36.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -26x~299x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: RTX faces margin compression risk, as evidenced by the sequential decline in Q4 net margin to 6.69% from 8.53% and a quarterly gross margin (19.46%) below its TTM average. While revenue growth is strong at 12% YoY, this margin pressure threatens the earnings growth required to support its elevated P/E ratio of 36.5x. The company also carries execution risk on multi-billion dollar, fixed-price defense contracts like Golden Dome, where cost overruns—highlighted by news of a potential $1.2 trillion total cost—could directly impair profitability. Furthermore, its commercial aerospace segment (Pratt & Whitney, Collins) remains exposed to cyclical downturns and airline failures, as recent news on Spirit Airlines and rising fuel costs illustrates.
Market & Competitive Risks: The primary market risk is valuation compression. RTX's forward P/E of 24.5x represents a premium to the industrials sector, making it vulnerable to a sector-wide de-rating if interest rates remain elevated or growth expectations falter. Its low beta of 0.306, while defensive, also means it may not participate fully in market rallies. Competitively, the defense industry is undergoing rapid change with new entrants like Rocket Lab targeting its core missile defense markets, potentially eroding long-term pricing power and market share. Geopolitical tensions, while a demand driver, also introduce volatility and the risk of program delays or budget reallocations.
Worst-Case Scenario: The worst-case scenario involves a perfect storm of defense program execution failures, sustained margin erosion, and a broader market sell-off in growth-oriented industrials. Specifically, a major cost overrun and delay on the Golden Dome program triggers a wave of analyst downgrades and contract renegotiations. Simultaneously, a recession hits commercial aerospace, causing order cancellations at Pratt & Whitney. This leads to consecutive earnings misses, forcing a severe de-rating of the P/E multiple toward its historical low near 19x. In this adverse scenario, the stock could realistically revisit its 52-week low of $140.47, representing a downside of approximately -24% from the current price of ~$185.6.